[1]
Wang, X. 2022. Effectiveness and safety of Osimertinib on non-small cell lung cancer therapy. Highlights in Science, Engineering and Technology. 6, (Jul. 2022), 328–335. DOI:https://doi.org/10.54097/hset.v6i.977.